OP0156 Simple assessment of conventional 18f-fdg pet/ct accurately diagnoses cranial arteritis in glucocorticoid-naÏve gca patients: a case-control study. (12th June 2018)

• Record Type: Journal Article
• Authors: Nielsen, B.D; Hansen, I.T.; Haraldsen, A.; Kramer, S.; Keller, K.K.; Therkildsen, P.; Hauge, E.-M.; Gormsen, L.C.
• Is Part Of: Annals of the rheumatic diseases. Volume 77(2018)Supplement 2
• Page Start: 129
• Page End: 129
• Publication Date: 2018-06-12
• Subjects: Rheumatism -- Periodicals; 616.723005
• DOI: 10.1136/annrheumdis-2018-eular.1338
• Languages: English
• ISSNs: 0003-4967

Abstract

Abstract : Background: Although older studies argue that fluorine-18-fluorodeoxyglucose (FDG) positron emissions tomography (PET)/CT cannot demonstrate inflammation in cranial arteries the spatial resolution of modern PET systems have greatly improved allowing for more precise diagnostics of small structures. FDG PET/CT is widely used to diagnose large-vessel (LV) giant cell arteritis (GCA). Recognising FDG uptake in cranial arteries potentially adds to FDG PET/CTs diagnostic accuracy for GCA. Objectives: To evaluate the diagnostic accuracy of conventional FDG PET/CT of the cranial arteries in GCA. Methods: In a cohort of consecutively included glucocorticoid-naïve patients suspected of new-onset GCA, patients full-filling 1990 ACR criteria for GCA were identified. Conventional FDG PET/CT and clinical assessment was performed before treatment. Controls were age- and sex-matched patients with malignant melanoma (MM) who had a metastatic-disease-free follow-up FDG PET/CT≥6 months after MM resection. All PET images were evenly cropped to include only head and neck. Images were randomly assessed by 2 nuclear medicine physicians (10 years experience) blinded to clinical symptoms and findings. Training included review of 5 GCA-PET examinations (not part of cohort). Temporal (TA), maxillary (MA) and vertebral (VA) arteries were visually scored bilaterally. Arterial FDG uptake above surrounding tissue was considered indicative of inflammation and graded low or high. If disagreement between readers occurred, final score was settled by an expert nuclear medicine physician. Student t test was used for quantitative data. Inter-reader agreement was evaluated by Cohens weighted kappa (disagreement on diagnosis weighted 0, disagreement on FDG uptake intensity weighted 0.2). Results: A total of 44 patients and 44 controls were identified. In both case and control group, the mean age was 69 years (p=0.45) and 25/44 were women. Large-vessel involvement was seen in 39/42 patients, and 35/42 were temporal artery biopsy positive. GCA patients' median global assessment of disease activity was 8 (IQR: 5–10) and median CRP was 70 (95% CI: 58; 85) mg/L. Considering only FDG uptake in TA and/or MA, diagnostic sensitivity and specificity was 66% (95% CI: 50%–80%) and 100% (95% CI: 92%–100%). Including VA, sensitivity increased to 86% (95% CI: 73%–95%) and specificity remained high, 98% (95% CI: 88% to 100%). Cohens weighted kappa was 0.82 (agreement 93%, p=0.000) in a per segment analysis and kappa was 0.84 (agreement 92%, p=0.000) in diagnosis. Conclusions: Inter-reader agreement on FDG uptake in cranial arteries is almost perfect, and cranial arteritis in glucocorticoid-naïve GCA patients can be readily and accurately diagnosed by conventional FDG PET/CT. The high diagnostic specificity suggests that TAB can be avoided in patients with FDG uptake in cranial arteries. Moreover, FDG PET/CT performed in patients with suspected vasculitis should always include head and neck. Disclosure of Interest: None declared